[go: up one dir, main page]

NO20042012L - Sammensetning og fremgangsmate for behandling av diabetes - Google Patents

Sammensetning og fremgangsmate for behandling av diabetes

Info

Publication number
NO20042012L
NO20042012L NO20042012A NO20042012A NO20042012L NO 20042012 L NO20042012 L NO 20042012L NO 20042012 A NO20042012 A NO 20042012A NO 20042012 A NO20042012 A NO 20042012A NO 20042012 L NO20042012 L NO 20042012L
Authority
NO
Norway
Prior art keywords
composition
treating diabetes
diabetes
treating
Prior art date
Application number
NO20042012A
Other languages
English (en)
Norwegian (no)
Inventor
Aaron I Vinik
Lawrence Rosenberg
Gary Pittenger
David Taylor-Fishwick
Michael Salem
Original Assignee
Gmp Endotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gmp Endotherapeutics Inc filed Critical Gmp Endotherapeutics Inc
Publication of NO20042012L publication Critical patent/NO20042012L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/474—Pancreatic thread protein; Reg protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4733—Acute pancreatitis-associated protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20042012A 2001-10-16 2004-05-14 Sammensetning og fremgangsmate for behandling av diabetes NO20042012L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32933001P 2001-10-16 2001-10-16
PCT/US2002/032904 WO2003033808A2 (fr) 2001-10-16 2002-10-15 Composition et methode de traitement du diabete

Publications (1)

Publication Number Publication Date
NO20042012L true NO20042012L (no) 2004-07-16

Family

ID=23284879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042012A NO20042012L (no) 2001-10-16 2004-05-14 Sammensetning og fremgangsmate for behandling av diabetes

Country Status (20)

Country Link
US (2) US20040132644A1 (fr)
EP (1) EP1435995A2 (fr)
JP (1) JP2005506362A (fr)
KR (1) KR20050036865A (fr)
CN (1) CN1723034A (fr)
BR (1) BR0213291A (fr)
CA (1) CA2463769A1 (fr)
CO (2) CO5570658A2 (fr)
CZ (1) CZ2004479A3 (fr)
HU (1) HUP0401612A3 (fr)
IL (1) IL161073A0 (fr)
MA (1) MA27503A1 (fr)
MX (1) MXPA04003526A (fr)
NO (1) NO20042012L (fr)
PE (1) PE20030608A1 (fr)
PL (1) PL370069A1 (fr)
RU (1) RU2004114865A (fr)
SK (1) SK1702004A3 (fr)
WO (1) WO2003033808A2 (fr)
ZA (1) ZA200402261B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009516A1 (en) * 2002-10-24 2006-01-12 Mcgill University Use of ingap for reversing diabetes
US20090142338A1 (en) * 2005-03-04 2009-06-04 Curedm, Inc. Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions
WO2006096565A2 (fr) * 2005-03-04 2006-09-14 Curedm Inc. Methodes et compositions pharmaceutiques pour traiter des diabetes sucres de type 1 et d'autres troubles
EP2295066B1 (fr) * 2005-05-25 2016-04-27 CureDM Group Holdings, LLC Peptides, dérivés et analogues associés et procédés d'utilisation associés
EP1840573A1 (fr) * 2006-03-27 2007-10-03 Institut Pasteur Protéines sécrétées en tant que marqueurs précoces et cibles médicamenteuses pour l'auto-immunité, la tumorigenèse et les infections
WO2008064306A2 (fr) * 2006-11-22 2008-05-29 Curedm, Inc. Procédés et compositions se rapportant à la néogenèse des cellules des îlots de langerhans
PT2193142E (pt) * 2007-08-30 2015-04-22 Curedm Group Holdings Llc Composições e procedimentos de utilização de peptídeos pro-ilhota e seus análogos
JP2015533821A (ja) * 2012-09-27 2015-11-26 クラレッサ レヴェタンＣｌａｒｅｓａ ＬＥＶＥＴＡＮ 新たな膵臓ベータ細胞の生成
CN104045699A (zh) * 2013-03-15 2014-09-17 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
WO2014139182A1 (fr) * 2013-03-15 2014-09-18 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions et méthodes d'utilisation de peptides de néogenèse d'îlots et d'analogues de ceux-ci
CN104045698B (zh) * 2013-03-15 2019-04-16 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
CN104045702A (zh) * 2013-03-15 2014-09-17 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
CN103305457B (zh) * 2013-06-06 2015-07-08 浙江省医学科学院 一种体外扩增胰岛β细胞的方法
US20160039876A1 (en) * 2014-03-28 2016-02-11 Claresa Levetan Insulin independence among patients with diabetes utilizing an optimized hamster reg3 gamma peptide
CN109195983B (zh) * 2016-03-10 2022-05-17 深圳君圣泰生物技术有限公司 胰岛新生多肽和类似物的缀合物及其方法
WO2020036918A1 (fr) * 2018-08-15 2020-02-20 Wake Forest University Health Sciences Formulations améliorées pour l'encapsulation d'îlots pancréatiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US127624A (en) * 1872-06-04 Improvement in apparatus for elevating water
US4658957A (en) * 1985-01-28 1987-04-21 Abbott Laboratories Utility tray
US6106840A (en) * 1988-06-23 2000-08-22 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
JP4111539B2 (ja) * 1995-02-22 2008-07-02 イースタン・ヴァージニア・メディカル・スクール・オブ・ザ・メディカル・カレッジ・オブ・ハンプトン・ローズ 膵島新生に関与するｉｎｇａｐタンパク質
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
JP4426650B2 (ja) * 1996-05-03 2010-03-03 アボット・ラボラトリーズ 新規な抗血管形成ペプチド、それをコードするポリヌクレオチド、および血管形成を阻害する方法
US6090577A (en) * 1997-05-22 2000-07-18 Incyte Pharmaceuticals, Inc. Disease associated acidic protein
US6986994B2 (en) * 2001-01-09 2006-01-17 Gmp Endotherapeutics, Inc. INGAP displacement assays

Also Published As

Publication number Publication date
WO2003033808A2 (fr) 2003-04-24
MXPA04003526A (es) 2004-07-22
PE20030608A1 (es) 2003-08-26
ZA200402261B (en) 2004-09-28
CA2463769A1 (fr) 2003-04-24
MA27503A1 (fr) 2005-09-01
CO5590933A2 (es) 2005-12-30
JP2005506362A (ja) 2005-03-03
RU2004114865A (ru) 2005-05-27
US20040132644A1 (en) 2004-07-08
WO2003033808A3 (fr) 2003-09-18
HUP0401612A3 (en) 2006-04-28
CZ2004479A3 (cs) 2005-01-12
CO5570658A2 (es) 2005-10-31
HUP0401612A2 (hu) 2004-12-28
BR0213291A (pt) 2004-10-26
EP1435995A2 (fr) 2004-07-14
IL161073A0 (en) 2004-08-31
KR20050036865A (ko) 2005-04-20
CN1723034A (zh) 2006-01-18
PL370069A1 (en) 2005-05-16
US20080171704A1 (en) 2008-07-17
SK1702004A3 (sk) 2005-03-04

Similar Documents

Publication Publication Date Title
NO20040873L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
NO20035611D0 (no) Sammensetning og fremgangsmåte for kontroll ved behandling av hydrokarbon
NO20044148L (no) Sammensetning og fremgangsmate for bronnrensing
NO20041005L (no) Fremgangsmate og anordning for sammensening av gjenfestbare absorberende klesplagg
DK1231887T3 (da) Fremgangsmåde og sammensætning til behandling af ar
NO20035256D0 (no) Fremgangsmåte og anordning for fremstilling av ben-sement
AU2002364364A8 (en) Method of treating apoptosis and compositions thereof
AUPR638101A0 (en) Composition and method for treatment of disease
NO20042012L (no) Sammensetning og fremgangsmate for behandling av diabetes
GB0110288D0 (en) Composition and treatment method
NO20005017L (no) Metoder og viskøse sammensetninger for behandling av brønner
FI20011403L (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
DK1949936T3 (da) Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
DK1463683T3 (da) Fremgangsmåde og arrangement ved ladesøjle
NO20033746D0 (no) Fremgangsmåte og blanding for syrebehandling av en underjordisk formasjon
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
IL165304A0 (en) Method of treating diabetes
NO20034531D0 (no) Brönnbetjeningsfluid og fremgangsmåte for fremstilling og anvendelse av dette
NO20041076L (no) Anlegg og fremgangsmate for stoping, saerlig av elektroder
DK2457582T3 (da) Fremgangsmåde og sammensætningertil kontrol af ektoparasitter
IS6888A (is) Aðferð við meðferð sykursýki af gerð I
FI20031678A0 (fi) Näytteen käsittelymenetelmä ja järjestely siihen
DK1441746T3 (da) Sammens tning og fremgangsmode
GB2399500B (en) Composition and method for treatment of wounds
NO20011176L (no) Fremgangsmåte og anordning ved merd

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application